Usage of Cox-Regression Model for Forecasting of Survival Rate in Patients with the Early Stage of Non-Small Cell Lung Cancer
Oleksey P. Kolesnik, Anatoliy I. Shevchenko, Yuriy E. Lyakh, Vitaliy G. Gurianov, Pavel A. Alyoshechkin

Adv. Lung Cancer Vol.3 No.1, March 17, 2014
DOI:10.4236/alc.2014.31004

Five-Year Survivors of Non-Small Cell Lung Cancer Patients with Positive Pleural Lavage Cytology
Masaki Tomita, Takanori Ayabe, Eiichi Chosa, Kunihide Nakamura

Adv. Lung Cancer Vol.3 No.1, February 24, 2014
DOI:10.4236/alc.2014.31003

A Phase II Study of Erlotinib in Patients with Previously Treated Non-Small Cell Lung Cancer
Tetsuya Kubota, Yoshio Okano, Mizu Sakai, Takashi Yamane, Naoki Shiota, Hiroshi Ohnishi, Hisanori Machida, Nobuo Hatakeyama, Eiji Takeuchi, Tomoyuki Urata, Fumitaka Ogushi, Akihito Yokoyama

Adv. Lung Cancer Vol.3 No.1, February 18, 2014
DOI:10.4236/alc.2014.31002

Feasibility Study for Biweekly Administration of Cisplatin plus Vinorelbine as Adjuvant-Chemotherapy for Completely Resected Non-Small Cell Lung Cancer Patients in a Japanese Population
Shuichi Tsukamoto, Koji Yamazaki, Ryo Mori, Masakazu Katsura, Hidenori Kouso, Daigo Kawano, Chie Ushijima, Sadanori Takeo

Adv. Lung Cancer Vol.3 No.1, February 18, 2014
DOI:10.4236/alc.2014.31001